Status:
COMPLETED
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
Aventis Pharmaceuticals
Conditions:
Alzheimer's Disease
Dementia
Eligibility:
All Genders
18-90 years
Brief Summary
Patients with different types of dementia will be recruited and evaluated in national hospital departments for their usual neurological follow-ups. A blood sample will be proposed in the field of this...
Eligibility Criteria
Inclusion
- Patients presenting with a neurodegenerative disorder with cognitive impairment controls (without signs of the disease), matched with sex and age with the patients
- Relatives for the familial cases
Exclusion
- Pregnant women
- Minors
- Persons refusing to sign the informed consent
Key Trial Info
Start Date :
December 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
2256 Patients enrolled
Trial Details
Trial ID
NCT00149175
Start Date
December 1 2002
End Date
December 31 2020
Last Update
January 23 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Côte de Nacre
Caen, France, 14000
2
Hôpital Sainte-Marguerite
Marseille, France, 13009
3
Hôpital Guillaume et René Laennec
Nantes, France, 44000
4
Hôpital de l'Archet
Nice, France, 06000